1 / 76

DEMENTIA & DELIRIUM

DEMENTIA & DELIRIUM. UNC PSYCHIATRY - 2008. DEMOGRAPHICS OF AGING. >85 is fastest growing demographic group 20% of population by 2030 will be over 65 There will be more women than men Life expectancy : (F > M) 1900 47.3 yrs 1985 74.4 yrs 2001 77.0 yrs

avon
Télécharger la présentation

DEMENTIA & DELIRIUM

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DEMENTIA & DELIRIUM UNC PSYCHIATRY - 2008

  2. DEMOGRAPHICS OF AGING • >85 is fastest growing demographic group • 20% of population by 2030 will be over 65 • There will be more women than men • Life expectancy: (F > M) • 1900 47.3 yrs • 1985 74.4 yrs • 2001 77.0 yrs • Psychiatric Disorders LESS prevalent except cognitive impairment

  3. Prevalence of Memory Impairment

  4. Dementia: An acquiredsyndrome characterized by: • Short-term memory impairment AND • At least one of the following: • Aphasia - language impairments • Apraxia - motor memory impairments • Agnosia - sensory memory impairments • Abstract thinking / Exec. function impairments • Impairment in social and/or occupational fn • Not explainable by another disorder

  5. Epidemiology: Prevalence of dementia increases with age *Lower numbers represent moderate to severe dementia

  6. Life Expectancy

  7. Incidence Of Alzheimer’s Disease by Age

  8. Prevalence of AD vs All-cause Dementia By Age

  9. Etiology & Pathogenesis • Dementia results from impaired functioning of multiple brain systems in both cortical and sub-cortical areas that are associated with short-term memory (i.e. learning) and other higher cognitive functions. Generally this is due to structural brain damage that is often progressive and relatively irreversible

  10. Classification of Dementias • Primary versus secondarybased on the pathophysiology leading to damaged brain tissue • Cortical versus sub-corticaldepending on the cerebral location of the primary deficits • Reversible versus irreversibledepending on optimal treatment expectations • Early (before age 65) versus late onset

  11. Most Common Dementias • Alzheimer’s Disease and Lewy Body Dementias (50-75%) • Vascular Dementias (15-20%) • Alcohol-related dementias (including Korsakoff’s (infrequent) and etoh-induced)) • In those under age 65, FTDs may comprise 50% of all dementias • HIV dementia - most common dementia in those under age 55

  12. ALZHEIMER’S Pathophysiology • Neuritic plaques -extracellular - abnormal insoluble amyloid (beta) protein fragments • Neurofibrillary tangles - intracellular - disturbed tau-microtubule complexes (hyperphosphorylated tau) • Cholinergic system degeneration with significant loss of neurons in certain areas (such as Nucleus Basalis of Meynert) • Degeneration often begins in enterorhinal cortex and progresses to other limbic structures

  13. Lewy Body Pathology • Concentric spheres found within vacuoles (eosinophilic cytoplasmic inclusions) • Seen in cortex, midbrain and brainstem neurons in patients with idiopathic parkinsonism, Alzheimer's disease and especially Lewy Body dementias • The main structural component is alpha-synuclein. Ubiquitin is sometimes seen also.

  14. Risk Factors for AD • Age • Family history • Down’s syndrome (trisomy 21) • Head Trauma (esp. late in life) • Female gender (mixed results: age bias and possible higher ‘clinical’ expression in women) • Ethnicity (Caucasians have the lowest risk) • Late-onset depression (after age 65) • Mild Cognitive Impairment (MCI)

  15. Additional Risk Factors for Dementia • Cerebrovascular disease (and the risk factors for CV disease – including smoking, diabetes, hyperlipidemia, hypertension) is associated with vascular dementia risk • Recurrent MDD may be associated with risk of dementia in general.(Kessing and Anderson found risk of dementia to be 6 times higher in patients with 5 or more prior episodes.)1 • Subclinical Hyperthyroidism (especially when antithyroid antibodies are present.2 1Kessing LF, Anderson PK. J Neurol Neurosurg Psychiatry. 2004;75:1662-1666 2Kalmijn S, Mehta KM, Pols HA, et al. Clin Endocrinology (Oxf) 2000;53:733-737

  16. Genetic risk factors • Chromosome 19 - autosomal recessive - Apolipoprotein E-4 allele - associated with late-onset disease (not relevant for non-caucasians) • Chromosome 1, 14, 21 - autosomal dominant mutations - associated with early-onset/familial cases. Amyloid processing genes. • Chromosome 9 – ‘ubiquilin 1’ polymorphisms – needs replication

  17. Protective Factors in AD • Education • Anti-inflammatory agents (those that decrease amyloid production) • Estrogen replacement therapy (+/-) • Smoking (+)[?nicotine/past use](-) [CVD/current use] • APO E-3, CETP VV • Vitamin E & other antioxidants? • Homocysteine reduction • Statin use?

  18. Vascular dementia • Includes Binswanger’s disease, MID, anoxic damage, post-CABG, inflammatory diseases • RISK FACTORS: age, hypertension, diabetes and hyperlipidemia • 2nd most common dementia but incidence drops after the age of 75 (unlike Alzheimer’s disease) • In one study, 87% of ‘vascular dementias’ at autopsy had AD pathology1 1Nolan KA, Lino MM, et al. J Am Geriatr Soc, 1998;46:597-604

  19. Other less common dementias • Primary degenerative dementias • Diffuse Lewy Body dementias (7-26% of dementias) • Frontotemporal dementias (Pick’s, ALS, Huntington’s) • Neurological disordersassociated with dementia • PSP, Parkinson’s dementia, NPH, neoplasms, head trauma, subdurals, demyelinating diseases

  20. Less common dementias (cont.) • Infectious causes • neurosyphilis, Lyme disease • post-encephalitic dementias (esp. herpes) • viral, parasitic, bacterial and fungal meningitidies • opportunistic infections or brain abscess • Human prion disease (transmissible spongiform encephalopathies) - sCJD, ‘Mad-cow disease’(vCJD), Kuru, fatal familial insomnia

  21. General medical causes of dementia • Thyroid and adrenal diseases • Vitamin deficiency states (thiamin, niacin, B12) • Metabolic derangements (hepatic encephalopathy, dialysis dementia, etc.) • Medications(sedatives, antihypertensives, narcotics, anticholinergics) • Whipple’s Disease, sarcoidosis, Wilson’s disease • Toxins (heavy metals, organic poisons)

  22. Rapidly Progressive Dementias • Hashimoto’s Encephalitis (treatable with steroids) • Cerebellar degeneration syndromes • Transmissible spongifrom encepalopathies (prion diseases) • Paraneoplastic syndromes • Postviral encephalitis • Rare cases of AD, DLB, FTD

  23. Clinical Presentation • Always associated with cognitive disturbances and functional impairments • Visuospatial impairments and behavioral disturbances are usually seen as well • Specific symptoms will vary by type of dementia

  24. Memory Impairments • Difficulty learning or retaining new information (repeated conversations) • Information retrieval deficits (can’t recall names, list generation deficits) • Personal episodic memory impairment (misplacing items) • Declarative (semantic) memory (WHAT) > procedural (implicit) memory (HOW)

  25. Language Deficits • List-generation deficits (esp. in AD) • Word-finding difficulties (naming problems) • Verbal fluency deficits • Less complex sentence structure • Relatively preserved auditory comprehension (can understand directions)

  26. Visuospatial impairments • Visual recognition impairments (trouble recognizing familiar faces - CAPGRAS syndrome possible) • Spatial deficits (getting lost in familiar surroundings, 3-D drawing deficits)

  27. Executive Function Impairments • Planning, predicting, correlating, abstracting –> Frontal lobe F’n • Taking multiple threads of information and processing it to make a decision (Trails B testing) • Often the first impairment noticed in highly educated/intelligent people • Pronounced deficits often seen in FTDs before overt memory impairment

  28. Functional Impairments • Deficits appear first in IADLs (managing finances, driving, shopping, working, taking medications, keeping appointments) • Eventually problems with ADLs (feeding, grooming, dressing, eating, toileting) • Rate and specific pattern of loss will vary by individual and somewhat by diagnosis • NB: Functional impairment and performance on cognitive testing may not correlate strongly early in the course of dementia

  29. Behavioral Symptoms • Nearly universal and often the main focus of treatment. Inability to manage these symptoms is highly correlated with institutional placement. • PERSONALITY CHANGE: Occurs early • passivity (apathy, social withdrawal) • disinhibition (inappropriate sexual behavior or language) • self-centered behaviors (childishness, loss of generosity)

  30. Agitation • Very common and frequently worsens as the illness progresses • verbal aggression (25%) • physical aggression (30%) • non-aggressive behaviors such as wandering and pacing (25-50%)

  31. Other Associated Features • Depression (40-50%) - esp. in AD & VD • Psychosis • Delusions (30-60%) • Paranoid type (theft, infidelity) • Misidentification type (Capgras, etc.) • Perceptual disturbances (20-40%) - often visual, common in LBD • Sleep Disturbances (>50%) - insomnia, sleep-wake cycle problems. This plus wandering and aggression are highly correlated with care-giver burnout

  32. Course & Staging of Dementia • Most have insidious onset with progressive decline over many years • Some are fulminate (JCD e.g.) • Some may remit spontaneously or with treatment (e.g. Thyroid disease, B12 def.) • AD - Predictable progression which is the reverse of development. Typically live 4 -10 years after diagnosis and often have symptoms 3-4 years before diagnosis. Women usually outlive men.* • VD - May show step-wise progression. Shorter course than AD. Often see focal findings *Ann Intern Med (2004) Average survival after diagnosis of AD: 5.7 years for women, 4.2 years for men

  33. DIFFERENTIAL DIAGNOSIS • Amnestic syndrome - STM impairments alone • Receptive Aphasia - Impaired cognitive functioning due to failure to understand speech • Mental Retardation - Impaired intellectual abilities but not necessarily memory • Pseudodementia (Dementia Syndrome of Depression). 50% of elderly patients with Depressive Pseudodementia go on to develop irreversible dementia within 3-5 years!

  34. DIFF DX (continued) • Are-related cognitive decline: AKA Age-associated Memory Impairment (AAMI), Benign Senescent Forgetfulness or Mild Cognitive Impairment (MCI). Symptoms not currently associated with functional impairment. However, ~25%-35% progress to dementia within 18 months. • Delirium - Impairments of consciousness and attention. Commonly seen in dementia

  35. DELIRIUM • Acute brain dysfunction characterized by: • Global symptoms (affecting both cerebral hemispheres) including impairment of consciousness and attention • Primary physiological changes with potential for reversibility • ‘waxing and waning’ symptoms – usually worse in evening • Life-threatening conditions underlying the syndrome

  36. Symptoms of Delirium • Common symptoms of a delirium include: • Waxing and waning levels of consciousness • Poor attention and disorientation • Disturbed memory (long and short term) • Psychosis • Sleep dysregulation • Fearfulness with agitation and aggression • Seriously impaired insight and judgment

  37. Epidemiology of Delirium • Very Common - 10-15% med/surg inpatients (30%+ if elderly) • 30% of Adult Burn Patients • 80%of delirious patients have pre-existing dementia • Predisposing Factors: old age, postcardiotomy, s/p burns prexisting brain damage drug withdrawal states AIDS

  38. Causes of Delirium • Often multifactorial • Infections, trauma, brain diseases • Cardiac diseases, lung disease, hypoxia, hypoglycemia • Toxins, or intoxications • Medication effects • Substance withdrawals (e.g. DTs) • Endocrinopathies • In elderly dementia patients: UTI, dehydration and pneumonia are the most common causes

  39. DELIRIUM - TREATMENT • Must look for medical cause(s) and treat • Symptoms can be helped by antipsychotic drugs such as haldoperidol or risperidone (especially psychosis, agitation) • Consider anticholinesterases for anticholinergic delirium • Comfort measures include reorientation strategies, reducing stimulation, frequent reassurance

  40. Delirium vs Dementia(summary) • General rules of thumb: DeliriumDementia acute chronic reversible irreversible physiological structural primary attention primary memory deficits deficits • Delirium and dementia can coexist; in fact delirium is very common in demented patients

  41. Diagnostic ApproachEarly Detection & Screening • Careful history from patient and reliable informant • PE with focus on neurological exam and cognitive testing • Cognitive testing tools such as MMSE are helpful. Score below 24-27 often concerning depending on premorbid abilities • Functional Assessment tools such as the Functional Activities Questionnaire

  42. Cognitive Testing • Serial 7’s (5 answers) - If you can do it, that’s good, but as many as 50% of normal elderly can’t(WORLD backwards is not much better as only 62% of elderly can do it with no errors) • Orientation:If you are disoriented that’s bad, however many early dementia patients are fully oriented (40%) • 3-item recall: Not being able to recall 2/3 is bad as only 19% of dementia patients can do this, but 74% or normal elderly can • MMSE: Sensitivity: 87%, Specificity: 82%

  43. MMSE ‘norms’ by Age and Educational Level Educational level

  44. Diagnostic Work-Up • This is done to • (1) rule out disorders besides dementia, • (2) to identify reversible/treatable dementias (13%) • (3) to clarify the specific dementia syndrome • Routine Assessment: CBC with diff, serum electrolytes, Ca++, glucose, BUN/CR, LFTs, TFTs, B12 & folate, U/A, RPR • When indicated: Sed. rate, HIV, CXR, heavy metals, neuroimaging, LP, EEG, functional imaging, Lyme titers, endocrine studies, rheumatologic studies

  45. Guidelines for use of specialized testing • LP: Suspicion of metastatic CA, CNS infections, neuropsyphilis, hydrocephalus, vasculitis. Also for dementia <55 and rapidly progressive dementias • Neuroimaging - consider in all new cases. However when no focal symptoms or signs, seizures or gait disturbances in an individual over age 60 - consider this optional • Functional Imaging (SPECT, PET, MRS): to clarify type of dementia when necessary • EEG - can help distinguish delirium from dementia, can help with seizure disorder and CJD (periodic slow wave complexes)

  46. Biological Markers • Hyperphosphorylated tau protein in AD • P-tau231 and p-tau181 discriminate AD from non-AD dementias • Elevated p-tau231 in MCI predicts decompensation • Phosphorylation of threonine 231 is an early event in AD, and precedes tangle formation • CSF 14-3-3 protein – elevated in CJD • Neural Thread Protein (NTP) in urine – 60% sensitivity, 91 % specificity. Not helpful yet in mild cases (MCI) because elevations are 50/50 • Pittsburg B Compound (PIB) binds to abnormal B-amyloid fragments and is PET indentifiable

  47. Neuropsychological Testing • Cognitive testing and functional testing are at odds or there is suspicion of early dementia in a high IQ individual with normal MMSE • Mild impairment in a person with: low IQ or limited education, trouble with English, impairments less than 6 months • Determining capacity for legal purposes when deficits are mild

  48. General Treatment Principles For Dementia • Treatment Of Underlying Disease Process (Primary Treatment) • Management Of Behaviors and Symptoms (Secondary Treatment) • Caregiver Support and Education

  49. Reversible Dementias • May become irreversible if not treated soon enough • Many dementias may be arrestible if not fully reversible • Rule out ‘depressive pseduodementia’ and delirium which can mimic dementia • Some reversible dementias include: hypoT4, B12 def., some infections and tumors, drug-induced syndromes, etc.

  50. Primary Treatment Strategies(for progressive dementias) • 1. Prevention • Identify risks and mitigate • Develop neuroprotective strategies for those at risk • 2. Slow or halt progression of illness • Understanding pathophysiology leads to treatment ideas • 5 year delay in onset ---> 1/3 decrease in prevalence • Delaying institutionalization by 1 month saves $1.2 billion/yr • 3. Reverse symptoms • Compensate through augmentation of remaining neurons or other systems • Reversal of destructive processes & regeneration of tissue

More Related